{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:05:36Z","timestamp":1793711136503,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006149","name":"Oxford University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nmd.2025.106209","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T14:23:36Z","timestamp":1756045416000},"page":"106209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An observational longitudinal study of congenital myasthenic syndromes"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0956-0501","authenticated-orcid":false,"given":"Hayley","family":"Ramjattan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighann","family":"Henehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sithara","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.106209_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/practneurol-2012-000404","article-title":"Congenital myasthenic syndromes: an update","volume":"13","author":"Finlayson","year":"2013","journal-title":"Pract Neurol Neurol"},{"issue":"11","key":"10.1016\/j.nmd.2025.106209_bib0002","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00415-014-7520-7","article-title":"Inherited disorders of the neuromuscular junction: an update","volume":"261","author":"Rodr\u00edguez Cruz","year":"2014","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2025.106209_bib0003","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.106209_bib0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2020.02.002","article-title":"Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of Slovenia","volume":"26","author":"Troha Gergeli","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2025.106209_bib0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2009.177816","article-title":"Molecular characterisation of congenital myasthenic syndromes in Southern Brazil","volume":"81","author":"Mihaylova","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2025.106209_bib0006","article-title":"498P Neuromuscular centre effect on prevalence of congenital myasthenic syndrome (CMS) in the UK","volume":"43","author":"Rossini","year":"2024","journal-title":"Neuromuscul Disord [Internet]"},{"issue":"6","key":"10.1016\/j.nmd.2025.106209_bib0007","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2025.106209_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061677","article-title":"The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes. Vol. 19","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int J Mol Sci J Mol Sci"},{"key":"10.1016\/j.nmd.2025.106209_bib0009","article-title":"Congenital myasthenic syndromes in 2018","volume":"18","author":"Engel","year":"2017"},{"key":"10.1016\/j.nmd.2025.106209_bib0010","first-page":"1","article-title":"Genetic neuromuscular disorders: a case-based approach","volume":"9783319075","author":"Angelini","year":"2014","journal-title":"Genet Neuromuscul Disord: Case-Based Approach"},{"key":"10.1016\/j.nmd.2025.106209_bib0011","first-page":"943","article-title":"Congenital myasthenic syndromes: where do we go from here?","volume":"31","author":"Ramdas","year":"2021"},{"key":"10.1016\/j.nmd.2025.106209_bib0012","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J Rare Dis BioMed Cent Ltd"},{"issue":"5","key":"10.1016\/j.nmd.2025.106209_bib0013","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","article-title":"MG-ADL: still a relevant outcome measure","volume":"44","author":"Muppidi","year":"2011","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.106209_bib0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2012.06812.x","article-title":"The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice","volume":"1274","author":"Burns","year":"2012","journal-title":"Ann N Acad Sci"},{"issue":"8","key":"10.1016\/j.nmd.2025.106209_bib0015","article-title":"Quality of life in myasthenia gravis and correlation of MG-QOL15 with other functional scales","volume":"11","author":"Porras","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.nmd.2025.106209_bib0016","article-title":"Outcome measures in clinical trials of patients with Myasthenia Gravis","volume":"11","author":"Thomsen","year":"2020","journal-title":"Front Neurol Front Media SA"},{"issue":"5","key":"10.1016\/j.nmd.2025.106209_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098089","article-title":"A conceptual framework for evaluating impairments in myasthenia gravis","volume":"9","author":"Barnett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2025.106209_bib0018","first-page":"630","article-title":"Utilization of MG-ADL in myasthenia gravis clinical research and care","volume":"65","author":"Muppidi","year":"2022"},{"issue":"7","key":"10.1016\/j.nmd.2025.106209_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16280","article-title":"Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis","volume":"31","author":"Meisel","year":"2024","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.nmd.2025.106209_bib0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1212\/WNL.0000000000207278","article-title":"Addressing outcome measure variability in Myasthenia Gravis clinical trials","volume":"101","author":"Guptill","year":"2023","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2025.106209_bib0021","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2025.106209_bib0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","article-title":"The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers","volume":"13","author":"Barnett","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.nmd.2025.106209_bib0023","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","article-title":"MG-ADL: still a relevant outcome measure","volume":"44","author":"Muppidi","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2025.106209_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mus.26910","article-title":"Correlation of quantitative Myasthenia Gravis and Myasthenia Gravis activities of Daily living scales in the MGTX study","volume":"62","author":"McPherson","year":"2020","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2025.106209_bib0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/ene.13867","article-title":"Sensitivity of MG-ADL for generalized weakness in myasthenia gravis","volume":"26","author":"de Meel","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.106209_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123135","article-title":"Psychometric properties of MG-ADL items and MG-ADL score: an assessment of distributional characteristics, validity and factor structure in two large datasets","volume":"463","author":"Janssen","year":"2024","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.nmd.2025.106209_bib0027","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CND.0000000000000132","article-title":"A novel missense variant in the AGRN gene; congenital myasthenic syndrome presenting with head drop","volume":"18","author":"Karakaya","year":"2017","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.106209_bib0028","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JND-150098","article-title":"Congenital myasthenic syndromes with predominant limb girdle weakness","volume":"2","author":"Evangelista","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"6","key":"10.1016\/j.nmd.2025.106209_bib0029","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"M\u00fcller","year":"2007","journal-title":"Brain"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T03:04:51Z","timestamp":1763521491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625009368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S0960896625009368"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106209","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational longitudinal study of congenital myasthenic syndromes","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106209"}}